Latest News and Press Releases

Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million Cambridge, MA, November 6, 2020 – Summit (NASDAQ: SMMT) today announces that it has...

Summit Therapeutics Inc. (“Summit” or the “Company”) Summit Announces Agreement For a Fundraising of approximately $50 Million Cambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces...

Summit Therapeutics Inc.(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 ...

Summit Therapeutics Inc. (“Summit” or the “Company”) Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA Cambridge, MA, September 18, 2020 –...

Summit Therapeutics plc (“Summit” or the “Company”) Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020. ...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Announces Results of Court Meeting and General Meeting Oxford, UK, and Cambridge, MA, US, August 19, 2020 – Summit Therapeutics plc...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Announces Intention to Redomicile its Holding Company to the United States Oxford, UK, and Cambridge, MA, US, July 16, 2020 –...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome Health Oxford, UK, and Cambridge, MA, US, July 13, 2020...

Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Appoints Michael Donaldson as Chief Financial Officer Oxford, UK, and Cambridge, MA, US, June 8, 2020 – Summit Therapeutics plc...

Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020 ...